DCF — NORTHWEST MEDICAL CENTER
Enterprise Value: $-37.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-37.6M
Enterprise Value
$-19.5M
PV of Cash Flows
$-18.1M
PV of Terminal Value
$-29.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $301.9M | $3.7M | 1.0% | $-9.1M | $-8.3M |
| Year 2 | $311.0M | $6.9M | 2.0% | $-6.3M | $-5.2M |
| Year 3 | $320.3M | $10.3M | 3.0% | $-3.8M | $-2.9M |
| Year 4 | $329.9M | $12.3M | 4.0% | $-2.7M | $-1.8M |
| Year 5 | $339.8M | $13.5M | 4.0% | $-2.1M | $-1.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-37.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$293.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.007225457304518976
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5